Mixed medullary and papillary carcinoma of the thyroid: A case report  by Kung, Fang-Ping & Chen, Chien-Chin
lable at ScienceDirect
Tzu Chi Medical Journal 27 (2015) 133e134Contents lists avaiTzu Chi Medical Journal
journal homepage: www.tzuchimedjnl .comPathology PageMixed medullary and papillary carcinoma of the thyroid: A case report
Fang-Ping Kung a, Chien-Chin Chen b, c, *
a Department of Internal Medicine, Division of Endocrinology and Metabolism, Chia-Yi Christian Hospital, Chiayi, Taiwan
b Department of Pathology, Chia-Yi Christian Hospital, Chiayi, Taiwan
c Department of Cosmetic Science, Chia Nan University of Pharmacy and Science, Tainan, Taiwana r t i c l e i n f oArticle history:
Received 11 February 2015
Received in revised form
16 February 2015
Accepted 28 February 2015
Available online 7 May 2015A 53-year-old woman with a history of hypertension and right
breast cancer status after mastectomy presented with progressive
swelling of the neck in May 2013. She had no family history of
medullary thyroid carcinoma (MTC), hyperparathyroidism, or
pheochromocytoma. On physical examination, a soft, elastic,
2-cm nodule was palpated on the left side of the neck. The serum
levels of thyroid stimulating hormone and free thyroxine were
normal. Ultrasonography showed an isoechoic irregular
8.3 mm  7.6 mm  5.8 mm nodule in the right lobe of the thyroid,
and a hypoechoic heterogeneous 19.2 mm  18.7 mm  14.0 mm
nodule in the left lobe. Fine-needle aspiration cytology of the left
lobe nodule revealed scattered atypical cells. Based on the atypical
clinical features and patient request, a radical thyroidectomy and
central neck lymph node dissection were performed. During the
operation, the left thyroid nodule was found to have invaded the
strap muscles. An intraoperative pathology consultation on the left
thyroid nodule was deferred owing to diagnostic difﬁculty. After
the operation, the patient was discharged without complications.
Macroscopically, the right thyroid lobe measured
4.5 cm  3 cm  1.5 cm, and the left lobe measured
5.5 cm  3.0 cm  2.5 cm. After serial sections, a gray white soft
tumor mass, about 2.4 cm in diameter, was noted in the left-side
thyroid parenchyma, and the right side of the thyroid showed
vague goiter-like tan brown nodules.Conﬂict of interest: none.
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revealed one partially encapsulated nodular tumor composed of
solid sheets and follicles of neoplastic cells that were round to
polygonal, with large nucleoli, granular cytoplasm, and medium-
sized nuclei, separated by hyalinized collagen (Fig. 1A, hematoxy-
lin and eosin  40; Fig. 1B, hematoxylin and eosin  400). Foci of
calciﬁcation, atypical mitoses, and angioinvasion were noted. Am-
yloid deposition in the ﬁbrous stroma was proven by Congo red
staining under a polarizer. Immunochemical assays showed that
the neoplastic cells expressed calcitonin (Fig. 1C, 200), TTF-1,
synaptophysin, chromogranin A, and CD56, and failed to express
HBME-1 and cytokeratin 19. The features above were consistent
with medullary carcinoma. The two dissected lymph nodes were
negative for metastatic carcinoma. The histological results from the
right side of the thyroid showed three small foci (up to 3 mm in
diameter) of papillary microcarcinoma composed of tumor cells
arranged in papillary patterns with ground-glass nuclei and nuclear
grooves (Fig. 1D, hematoxylin and eosin 200).
Papillary thyroid carcinoma (PTC) is the most common histo-
logic type of thyroid carcinoma, accounting for 85e90% of all thy-
roid cancers [1]. MTCs comprise 5e10% of all thyroid carcinomas
[2], which differ from PTC in terms of their cell origin, histopath-
ological features, and clinical management. Mixed medullary and
papillary carcinoma of the thyroid has been documented in the
literature. Machens and Dralle [3] reported that the prevalence of
simultaneous medullary and papillary thyroid carcinomas in pa-
tients with PTC was about 2.6%, although the true prevalence is
unknown. The exact pathogenesis of two distinct types of thyroid
carcinoma in a thyroid gland is still controversial, but it has been
hypothesized that they derive from a common tumorigenic
pathway [4] or are coincidental ﬁndings with different genetic or-
igins [5e7]. In our case, the MTC and PTC components were iden-
tiﬁed in different thyroid lobes. This suggests independent tumors
and supports the theory of a coincidental event, although there was
no genetic analysis.
The prognosis for a patient with thesemixed thyroid carcinomas
is unclear because most reports in the literature are case reports
and long-term overall survival results are limited. Patients with
MTC have a worse prognosis than patients with PTC [8]. Therefore,
long-term follow-up of patients with mixed medullaryepapillary
carcinomas of the thyroid is mandatory.d by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. (A) There is one partially encapsulated nodular tumor composed of solid sheets and follicles of neoplastic cells in the left side of the thyroid (hematoxylin and eosin 40). (B)
The neoplastic cells are round to polygonal, with large nucleoli, granular cytoplasm, and medium-sized nuclei (hematoxylin and eosin 400). (C) Immunochemical assay shows the
neoplastic cells express calcitonin (200). (D) Histological results of the right side of the thyroid show three small foci (up to 3 mm in diameter) of papillary microcarcinoma
composed of tumor cells arranged in papillary patterns with ground-glass nuclei and nuclear grooves (hematoxylin and eosin 200).
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